Tests of global haemostasis and their applications in bleeding disorders
- 22 June 2010
- journal article
- review article
- Published by Wiley in Haemophilia
- Vol. 16 (s5), 85-92
- https://doi.org/10.1111/j.1365-2516.2010.02304.x
Abstract
There is a potential for significant paradigm shift in the assessment of haemostasis from the conventional plasma recalcification times, such as prothrombin time (PT) and activated partial thromboplastin time (APTT), which correspond to artificially created compartments of haemostasis to tests that assess the entire process in a more physiological and holistic manner. These include the thrombin generation test, thromboelastogram and the clot wave form analysis. While these tests have been described many years ago, there is renewed interest in their use with modified technology for assessing normal haemostasis and its disorders. Although early data suggest that they can provide much greater information regarding the overall haemostasis process and its disorders, many challenges remain. Some of them are possible only on instruments that are proprietary technology, expensive and are not widely available. Furthermore, these tests need to be standardized with regard to their reagents, methodology and interpretation, and finally, much more data need to be collected regarding clinical correlations with the parameters measured.Keywords
This publication has 36 references indexed in Scilit:
- Monitoring thrombin generation: Is addition of corn trypsin inhibitor needed?Thrombosis and Haemostasis, 2009
- High rate of unprovoked recurrent venous thrombosis is associated with high thrombin‐generating potential in a prospective cohort studyJournal of Thrombosis and Haemostasis, 2008
- New assays for monitoring haemophilia treatmentHaemophilia, 2008
- The Phenotypic Heterogeneity of Severe HemophiliaSeminars in Thrombosis and Hemostasis, 2008
- How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in AdultsMayo Clinic Proceedings, 2007
- ε-Aminocaproic acid inhibition of fibrinolysis in vitro: should the ‘therapeutic’ concentration be reconsidered?Blood Coagulation & Fibrinolysis, 2007
- Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastographyHaemophilia, 2006
- Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decisionHaemophilia, 2005
- Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and BThrombosis and Haemostasis, 2005
- Effectiveness of factor VIII infusions in haemophilia A patients with high responding inhibitorsHaemophilia, 2004